Immuneering Corp - 10-Q Filing

Immuneering Corp reports third quarter 2026 financial results including details on private placements and equity distribution agreements.

SEC EDGAR ·

Tickers: $IMRX

Read the full article at SEC EDGAR

More Regulatory news